Sphingotec GmbH

About:

SphingoTec develops innovative biomarkers for the diagnosis, prediction, and monitoring of acute medical conditions.

Website: https://sphingotec.com/

Twitter/X: sphingotec

Top Investors: Wellington Partners, NRW.BANK, Brandenburg Kapital, Think.Health, HBM Healthcare Investments

Description:

SphingoTec is a biomaker company that develops and markets in vitro diagnostic solutions for novel and proprietary blood-based protein biomarkers. They also develop microtiter plates, which are a standard tool in analytical research and diagnostic testing laboratories. They develop biomakers to address diagnostically underserved critical care conditions such as acute kidney injury, sepsis, and acute heart failure.